MSMFX
Price
$14.52
Change
-$0.17 (-1.16%)
Updated
Jun 22 closing price
Net Assets
774.31M
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

MSMFX vs VMGMX

MSMFX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
MSMFX vs. VMGMX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSMFX is a Hold and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. MSMFX (774M). VMGMX pays higher dividends than MSMFX: VMGMX (0.62) vs MSMFX (0.00). MSMFX was incepted earlier than VMGMX: MSMFX (9 years) vs VMGMX (15 years). MSMFX (1.78) is less costly to investors than VMGMX (0.07). MSMFX is a more actively managed with annual turnover of: 88.00 vs. VMGMX (17.00). MSMFX has a lower initial minimum investment than VMGMX: MSMFX (1000) vs VMGMX (3000). VMGMX annual gain was more profitable for investors over the last year : 11.76 vs. MSMFX (-3.61). VMGMX return over 5 years is better than : 31.10 vs. MSMFX (-55.75).
MSMFXVMGMXMSMFX / VMGMX
Total Expense Ratio1.780.072,543%
Annual Report Gross Expense Ratio1.780.072,543%
Fund Existence9 years15 years-
Gain YTD-0.9449.952-9%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets774M33.8B2%
Annual Yield % from dividends0.000.62-
Returns for 1 year-3.6111.76-31%
Returns for 3 years84.0955.53151%
Returns for 5 years-55.7531.10-179%
Returns for 10 yearsN/A213.13-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.59N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.09N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.35N/A
N/A
MFS Blended Research Value Equity R4